RxDoctor Payments Data

Lubna Momin

Family · Houston, TXNPI 1841724572

Payments from drug & device makers

$2,886in general payments, 2019–2025

Across 161 payments — averaging $17.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$562
  • AstraZeneca$484
  • Lilly USA, LLC$430
  • Novo Nordisk$274
  • Takeda Pharmaceuticals U.S.A., Inc.$210
  • Amgen$170
  • plus $756 from 18 others

What the payments were for

  • Food & beverage$2,886100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,886 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
PaxlovidNirmatrelvir/Ritonavir11$1,519
Azelastine-FluticasoneAzelastine/Fluticasone13$1,021
Ibandronate Sodium18$595
Albuterol Sulfate HfaAlbuterol Sulfate15$468
Atorvastatin Calcium42$462
Azelastine Hcl15$432
Omeprazole22$409
Clonazepam34$406
Levothyroxine Sodium62$320
Olmesartan Medoxomil11$295
Fluticasone Propionate29$291
Amlodipine Besylate47$291
Rosuvastatin Calcium40$256
ValacyclovirValacyclovir Hcl13$209
Doxycycline Hyclate24$175

Paid to pharmacies, not to this prescriber.

Other family in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →